Xylem (XYL) stock climbed 1.6% premarket after Q1 earnings of $1.12 per share beat estimates. The company raised its 2026 revenue guidance.
Browsing: Stocks
Sherwin-Williams (SHW) stock climbed 3% after beating Q1 estimates with $2.35 EPS and $5.67B sales, despite cautious guidance from leadership.
Corning (GLW) stock fell 10% as Q2 revenue forecast disappointed investors, overshadowing a Q1 earnings beat and robust optical communications growth.
Nvidia (NVDA) dropped 3.4% premarket as OpenAI missed revenue targets, sparking a semiconductor selloff affecting AMD, Arm, Broadcom, and others.
Nasdaq futures sink 0.9% as OpenAI disappoints ahead of IPO. Oil jumps to $104 on Iran standoff. Fed meeting starts with Big Tech earnings on deck.
Arm Holdings (ARM) stock dropped 8% Monday as investors locked in gains after a 50% rally. Earnings report due Wednesday amid valuation concerns.
Oracle (ORCL) stock plummeted 7.6% after WSJ reported OpenAI missed revenue targets, casting doubt on their $300B cloud deal. SoftBank and CoreWeave also fell.
Kimberly-Clark (KMB) reported Q1 2026 earnings of $1.60 per share, missing estimates by 17%, while revenue exceeded forecasts at $4.2 billion.
Rambus (RMBS) stock tumbles 18% after Q1 earnings beat but Q2 guidance underwhelms. Analysts split on the chip stock’s outlook amid AI memory demand.
Snap (SNAP) rallies 7% after Redburn Atlantic upgrade to Buy with $10 price target, citing subscription growth and improving margins. Is a turnaround coming?
Joby Aviation (JOBY) jumps 6% after NYC air taxi demo. Analysts set $18 price targets with 99% upside. Q1 earnings scheduled for May 5.
UPS (UPS) stock fell 3% despite beating Q1 earnings expectations as operating margins dropped to 6.2%, down from 8.2% year-over-year.
Lithium Americas Argentina (LAR) reached a 52-week high of C$13.25, gaining 5.5% with Strong Buy ratings, while LAC faces Thacker Pass cost inflation.
Spotify (SPOT) plunged 12% despite beating Q1 earnings. Weak Q2 operating income guidance and lower subscriber forecasts triggered the selloff.
Novartis (NVS) shares fell 2% after missing Q1 estimates with $13.11B sales. Entresto plunged 42% as CEO warns of U.S. drug pricing policy impact globally.